Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
36
datasets available to search
ShareScore release 0.9.0
Dataset results
36 results for “The VELOCE study”
GPS velocity field in the Pamir region in the Eurasian-fixed frame complied from our own results and previous studies
<p>The data file includes the GPS velocities with respect to the Eurasian frame in the Pamir, Tien Shan region.</p>
Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
ClinicalTrials.gov study NCT04067011. IPD Sharing: Not stated. Countries: 1. Publications: 1.
VELOCITY: An Anthrax Vaccine Clinical Study
ClinicalTrials.gov study NCT03877926. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
<p><b>Objective</b></p> <p><span>The phase IIIb VELOCE study (NCT02545868) assessed responses to selected vaccines in ocrelizumab (OCR)-treated patients with relapsing multiple sclerosis.</span></p> <p><b>Methods</b></p> <p>Patients were randomized 2:1 into Group OCR (n=68; OCR 600mg); or Control (n=34; interferon-β or no disease-modifying therapy). All received tetanus toxoid (TT)-containing vaccine, Pneumovax® (23-PPV) and keyhole limpet hemocyanin (KLH). Group OCR was subdivided into OCR1 (n=33) and OCR2 (n=35) at randomization. OCR1 received Prevnar® (13-PCV) 4 weeks after 23-PPV; OCR2 and Control received influenza vaccine. Vaccinations started 12 weeks after OCR initiation (Group OCR) or on Day 1 (Control).</p> <p><b>Results</b></p> <p>Positive response rate to TT vaccine at 8 weeks was 23.9% in OCR vs 54.5% in Control. Positive response rate to ≥5 serotypes in 23-PPV at 4 weeks was 71.6% in OCR and 100% in Control. Prevnar® did not enhance response to pneumococcal serotypes in common with Pneumovax®. Humoral response to KLH was decreased in OCR vs Control. Seroprotection rates at 4 weeks against five influenza strains ranged from 55.6–80.0% in OCR2 and 75.0–97.0% in Control.</p> <p><b>Conclusion</b></p> <p>Peripherally B-cell depleted OCR recipients mounted attenuated humoral responses to clinically relevant vaccines and the neoantigen, KLH, suggesting use of standard non-live vaccines while on OCR treatment remains a consideration. For seasonal influenza vaccines, it is recommended to vaccinate patients on OCR, as a potentially protective humoral response, even if attenuated, can be expected.</p>
The ambient noise cross-correlation function and teleseismic events, the Love-wave phase velocities, Rayleigh-wave phase and group velocities and H/V, Vsv and Vsh model in the study region (CNCC)
<p>The cross-correlation functions form EOBSArray (COR_CNCC), The Love-wave phase velocities (Love_phase), Rayleigh-wave phase (Rayleigh_phase) and group velocities (Rayleigh_group) and H/V (HtoV),and 3-D Vsv and Vsh model and related uncertainties (Vsv_Vsh_model) in the study region (CNCC) are archieved in the file named CNCC_data.7z.</p>
Dataset for the study of "Seismic fault slip at depths simulated by high-velocity friction experiments under hydrothermal conditions"
<p>These are measured data of high-velocity friction experiments conducted on gabbro and marble under hydrothermal conditions (initial ambient temperature of 40 to 400 degC and pore pressure of 30 MPa). </p> <p>In each txt file, Column1 to Column9: Time (s), Slip Velocity (m/s), Displacement (m), Friction coefficient, Axial Displacement (mm), Pore water pressure (MPa), Effective normal stress (MPa), Sample Temperature (degC) and Furnace Temperature (degC).</p>
FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent
ClinicalTrials.gov study NCT00233818. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.
ClinicalTrials.gov study NCT00235144. IPD Sharing: Not stated. Countries: 1. Publications: 5.
FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent
ClinicalTrials.gov study NCT00233792. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Alcohol Consumption and Arterial Stiffness: A Longitudinal Study of Pulse Wave Velocity in the Whitehall II Cohort
ClinicalTrials.gov study NCT02663791. IPD Sharing: YES. Countries: 1. Publications: 10.
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
ClinicalTrials.gov study NCT00489164. IPD Sharing: Not stated. Countries: 5. Publications: 1.
TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure
ClinicalTrials.gov study NCT02240394. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)
ClinicalTrials.gov study NCT00232765. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children
ClinicalTrials.gov study NCT02991703. IPD Sharing: Not stated. Countries: 0. Publications: 8.
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
Open the record for dataset details and reuse information.
The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.
ClinicalTrials.gov study NCT00381420. IPD Sharing: Not stated. Countries: 0. Publications: 3.
VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation
ClinicalTrials.gov study NCT02741297. IPD Sharing: NO. Countries: 4. Publications: 0.
Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
ClinicalTrials.gov study NCT00715884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)
ClinicalTrials.gov study NCT00449072. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of solar wind density and velocity variations on the Martian ionosphere and plasma transport—a MHD model study
<p>MHD simulation data for paper: Effects of solar wind density and velocity variations on the Martian ionosphere and plasma transport—a MHD model study</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.